Multiple Sclerosis
Dr. Michael Barnett discusses the positive clinical trial results of a treatment for ALS and MS.
Disease-modifying therapies for MS have shifted substantially since 2001, with more patients now taking oral medications.
A study sought to assess the mechanisms contributing to cognitive decline in MS.
Multiple sclerosis (MS) burden has become more prevalent, and more racially and ethnically diverse.
FibroBiologics is a clinical-stage company developing fibroblast-based therapies to treat chronic diseases. DocWire News ...
Minim Invasive Surg. 2021 Apr 19;2021:9969010. doi: 10.1155/2021/9969010. eCollection 2021.ABSTRACTOBJECTIVE: Spinal ...
Advertisement
Expert Interviews on Multiple Sclerosis
DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest medical updates and insights straight to your inbox.